NEW ASSOCIATION BETWEEN N-HYDROXY-4-{2-[3-(N,N-DIMETHYLAMINOMETHYL)BENZOFURAN-2-YLCARBONYLAMINO]ETHOXY}BENZAMIDE AND CISPLATIN IN CARCINOMA OF THE NASOPHARYNX
N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2-ylcarbonylamino] ethoxy}benzamide of formula (I): or an addition salt thereof with a pharmaceutically acceptable acid or base, in association with chemotherapy treatment or radiotherapy for use in the treatment of carcinoma of the nasopharynx.本發明係關於式(I)之N-羥基-4-{2-[3-(N,N-二甲基胺基甲基)苯并呋喃-2-基羰基胺基]乙氧基}苯甲醯胺,或其與醫藥上可接受之酸或鹼之加成鹽,與化學療法治療或放射療法結合用於治療鼻咽癌。